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Background
Maternal hyperoxygenation (MH) has been used for
intrauterine growth restriction and proposed as a way to
improve ventricular growth in fetuses with congenital
heart disease (CHD) [1,2]. Fetal lamb experiments reveal
increases in the SaO2 of umbilical venous (UV) blood
and reduction in pulmonary vascular resistance during
MH [3]. Doppler suggests that MH increases the human
fetal pulmonary blood flow (PBF) [4]. The combination
of fetal phase contrast (PC) MRI and MR oximetry using
T2 mapping offers a potential for comprehensive hemo-
dynamic assessment of late gestation fetal circulation [5].
We investigated the physiologic impact of MH in human
fetuses with and without CHD using MRI to explore the
potential therapeutic benefits of chronic MH.
Methods
We examined 17 normal human fetuses [mean GA of
37.3 wks; SD ± 1 wk) and 20 fetuses with CHD (mean
GA of 36.2 wks; SD ± 1 wk) on a 1.5T system (Siemens
Avanto, Erlangen, Germany) after hospital IRB approval.
Flows were measured in major fetal vessels using PC
MRI and indexed to fetal weight along with T2 of UV
blood according to our previously published technique
[5,6]. According to the Luz-Meiboom equation [7], the
T2 relaxation of blood is proportional to its O2 satura-
tion. The measurements were repeated during MH
(12 L/min of O2 via a non-rebreather mask, FiO2
∼70%). Results were compared using Student’s t-test,
with results with p-value ≤ 0.05 considered statistically
significant.
Results
At baseline, UV T2 was lower in CHD fetuses than in
normals. Although UV T2 did not change significantly
with MH in normals, we observed a significant increase
in UV T2 in CHD fetuses with MH (p=0.01, Fig. 1,
Table 1). Both groups showed a statistically significant
increase in PBF during MH but was more dramatic in
CHD fetuses (p=0.005). While there was a significant
reduction in ductus arteriosus (DA) flow in CHD fetuses
during MH (p=0.04), this was not present in normals.
There was no significant difference in blood flow in any
of the other major vessels.
Conclusions
The reason for lower O2 saturations in the UV of
fetuses with CHD is uncertain, but may reflect abnormal
placental and/or fetal cardiovascular function. The lower
position of UV blood saturation on the O2 dissociation
curve of hemoglobin may explain the higher uptake of
O2 from maternal plasma in CHD fetuses. The expected
increase in PBF with MH was observed in both groups.
This increase in PBF also explains the lower DA flow in
CHD fetuses with MH who had significantly higher DA
flow compared to normal at baseline (p=0.002). This
study suggests that fetal MR can assess hemodynamic
changes resulting from MH and could provide useful
additional fetal monitoring when MH is being used for
therapy.
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Figure 1 Physiologic impact of maternal hyperoxygenation (MH) in late gestation human fetuses with and without congenital heart disease
(CHD). At baseline, the umbilical venous (UV) T2 (a) was lower in CHD fetuses than in normals. Although the UV T2 did not change significantly
with MH in normals (b), we observed a significant increase in UV T2 in CHD fetuses with MH (p=0.01) (c). Both groups showed a statistically
significant increase in pulmonary blood flow (PBF) during MH (d), which was more dramatic in fetuses with CHD (p=0.005) (e, f). While there was
a significant reduction in ductus arteriosus (DA) flow in CHD fetuses during MH (p=0.04) (g,i), this was not present in normal fetuses (h). p ≤ 0.05
statistically significant.
Table 1 Average blood flow and T2 with maternal hyperoxygenation in human fetuses with and without congenital
heart disease
Normals CHD
Baseline MH p Baseline MH p
UV T2 (ms, n=5) 197.2 208.6 0.47 UV T2 (ms, n=8) 158.88 188.63 0.01
PBF(ml/kg/min, n=14) 74.57 114.1 0.02 PBF(ml/kg/min, n=11) 62.36 121 0.005
DA (ml/kg/min, n=13) 180.23 188.46 0.38 DA (ml/kg/min, n=11) 250.09 206.45 0.04
CHD: congenital heart disease, MH: maternal hyperoxygenation, UV: umbilical venous, PBF: pulmonary blood flow, DA: ductus arteriosus, p< 0.05 statistically
significant
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